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PREVALENCE OF THE USE OF CENTRAL VENOUS ACCESS
DEVICES WITHIN AND OUTSIDE OF THE INTENSIVE
CARE UNIT: RESULTS OF A SURVEY AMONG HOSPITALS
IN THE PREVENTION EPICENTER PROGRAM OF THE
CENTERS FOR DISEASE CONTROL AND PREVENTION
Michael Climo, MD; Dan Diekema, MD; David K. Warren, MD; Loreen A. Herwaldt, MD; Trish M. Perl, MD, MSc;
Lance Peterson, MD; Theresa Plaskett, MPH; Connie Price, MD; Kent Sepkowitz, MD; Steve Solomon, MD;
Jerry Tokars, MD, MPH; Victoria J. Fraser, MD; Edward Wong, MD

ABSTRACT
OBJECTIVE: To determine the prevalence of central
venous catheter (CVC) use among patients both within and outside the ICU setting.
DESIGN: A 1-day prevalence survey of CVC use among
adult inpatients at six medical centers participating in the
Prevention Epicenter Program of the CDC. Using a standardized
form, observers at each Epicenter performed a hospital-wide survey, collecting data on CVC use.
SETTING: Inpatient wards and ICUs of six large urban
teaching hospitals.
RESULTS: At the six medical centers, 2,459 patients were
surveyed; 29% had CVCs. Among the hospitals, from 43% to 80%
(mean, 59.3%) of ICU patients and from 7% to 39% (mean, 23.7%)
of non-ICU patients had CVCs. Despite the lower rate of CVC use
on non-ICU wards, the actual number of CVCs outside the ICUs

exceeded that of the ICUs. Most catheters were inserted in the
subclavian (55%) or jugular (22%) site, with femoral (6%) and
peripheral (15%) sites less commonly used. The jugular (33.0% vs
16.6%; P < .001) and femoral (13.8% vs 2.7%; P < .001) sites were
more frequently used in ICU patients, whereas peripherally
inserted (19.9% vs 5.9%; P < .001) and subclavian (60.7% vs 47.3%;
P < .001) catheters were more commonly used in non-ICU
patients.
CONCLUSIONS: Current surveillance and infection control efforts to reduce morbidity and mortality associated with
bloodstream infections concentrate on the high-risk ICU patients
with CVCs. Our survey demonstrated that two-thirds of identified
CVCs were not in ICU patients and suggests that more efforts
should be directed to patients with CVCs who are outside the
ICU (Infect Control Hosp Epidemiol 2003;24:942-945).

Central venous catheters (CVCs) are essential in
today’s healthcare environment. CVCs are extremely
prevalent in intensive care units (ICUs), with mean utilization rates ranging between 32% and 80% among adult
ICU patients.1 CVC use has increased in frequency in ICU
settings during the past decade with a concomitant rise in
complications associated with such use.1-5 Bloodstream
infections (BSIs) are the most serious complication of
CVC use. Primary catheter-associated BSIs are the third
leading cause of nosocomial infections and comprise 19%
of all such infections.1-3 Approximately 80% to 90% of all
primary BSIs are catheter related and most are due to
CVC use. Among different types of ICUs, the rates of
catheter-associated BSIs reported to the National
Nosocomial Infections Surveillance System range from
2.9 to 8.8 per 1,000 catheter-days.1 Risk factors for
catheter-associated BSI include the duration of catheteri-

zation, type of catheter, number of lumens, type of
infusate, insertion technique, site of insertion, site preparation, and certain host factors.6-11
The identification of these specific risk factors has
led to various strategies to prevent catheter-associated BSI
among ICU patients. Improvements in catheter insertion
techniques and care, maximal barriers use during CVC
insertion, and choice of catheter types have been employed
among ICU patient populations with success.12-18 Because
of the increasing acuity of the conditions of hospitalized
patients, patients on the wards and not just in the ICU are
increasingly requiring CVCs. However, little is known
about the epidemiology of CVC use outside of ICUs. We
therefore conducted a survey of CVC use among adult
inpatients at six medical centers participating in the
Prevention Epicenter Program of the Centers for Disease
Control and Prevention (CDC).
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CARE UNIT

ICU
Medical
Center
A
B
C
D
E
F
Total

No. of Patients
With CVCs/
Total
24/256 (9.38%)
144/431 (33.41%)
163/472 (34.53%)
154/554 (27.80%)
151/375 (40.27%)
82/371 (22.10%)
718/2,459 (29.20%)

No. of Patients
With CVCs/
Total
8/16
38/71
84/118
44/76
12/15
26/87
212/383

Non-ICU
Device
Utilization
Ratio

No. of Patients
With CVCs/
Total

Device
Utilization
Ratio

0.500
0.535
0.711
0.579
0.800
0.300
0.554

16/240
106/360
79/354
110/478
139/360
56/284
506/2,076

0.066
0.294
0.223
0.230
0.386
0.197
0.244

ICU = intensive care unit; CVC = central venous catheter.

METHODS

The study consisted of a 1-day point-prevalence survey at six major medical centers. Each is a large, academic-affiliated, tertiary-care referral center participating in
the Prevention Epicenter Program of the CDC. The
Prevention Epicenter Program is a consortium of seven
academic medical centers coordinated and funded by the
Division of Healthcare Quality Promotion of the CDC to
study the prevention of healthcare-associated complications and promotion of patient safety. At each medical center, trained personnel visually examined all hospitalized
patients for the presence of an indwelling CVC. For uniformity, the survey was conducted on a midweek day
during a 3- to 12-hour period.
All rooms and beds of each hospital, including those
of the ICU and the inpatient wards (non-ICU), were surveyed. Emergency departments, outpatient wards, recovery rooms, operating rooms, outpatient procedural rooms,
obstetric wards, ophthalmology wards, all pediatrics units
(including nursery and neonatal ICU), psychiatry wards,
and dialysis units were excluded from surveillance because
of the high use of specialized catheters in dialysis units and
the expected low prevalence of CVC use in the other areas.
A standardized data collection form was used to
note the location of the patient and whether a CVC was
present. For patients with a CVC, the form included the
site of catheter insertion, type of catheter, and hospital
ward and service. The time and place of the original
catheter insertion was not collected during this survey.
For the purposes of this study, we included the following
four classes of CVCs, which are based on classifications
previously established by the Infectious Diseases Society
of America, American College of Critical Care Medicine,
and Society for Healthcare Epidemiology of America18: (1)
tunneled central venous access catheters; (2) nontunneled central venous access catheters; (3) peripherally
inserted central catheters (PICCs); and (4) totally
implanted devices (ie, Portacath, Deltec, Inc., St. Paul,
MN). Sites of insertion were defined as either subclavian,

jugular, femoral, or peripheral for PICCs. Although access
devices inserted in the femoral area may not be considered to be contained within the central venous system,
data on their use were collected because their higher risk
of infection has been reported to exceed that of true central lines.7 Categorical data were analyzed using the chisquare test, with a P value of less than .05 considered significant.
RESULTS

Prevalence of CVCs
At the six medical centers, 2,459 patients were surveyed and overall 29% had CVCs (Table 1). Between 9.38%
and 40.27% (mean, 27.91%) of the patients surveyed within the participating medical centers had CVCs. CVC utilization rates were higher among the ICUs than among
the non-ICU wards. CVC utilization rates averaged 0.554
for ICU patients and only 0.244 for non-ICU patients.
Among the ICU patients, 212 (55.4%) of 383 had one or
more CVCs. The prevalence of CVCs was lower among
patients not located within the ICUs: 506 (24.4%) of 2,076
ward patients had one or more CVCs present. Despite the
lower rate of use on non-ICU wards, the actual number of
patients with CVCs outside the ICUs exceeded that from
the ICUs: 506 patients (70% of the total patients with
CVCs) outside the ICUs had CVCs, whereas only 212
patients (30% of the total patients with CVCs) in the ICUs
had CVCs (Table 2). Additionally, there were more than
twice as many CVCs among ward patients compared with
ICU patients (523 vs 238 CVCs, respectively).
Site of CVC Insertion
Most catheters were inserted in the subclavian
(55%) or jugular (22%) site, with femoral (6%) and peripheral (15%) insertion being less common (Fig. 1). Also, the
jugular site (33.0% vs 16.6%; P < .001) and the femoral site
(13.8% vs 2.7%; P < .001) were more frequently used in ICU
patients, whereas PICCs (19.9% vs 5.9%; P < .001) and subclavian catheters (60.7% vs 47.3%; P < .001) were more
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TABLE 2
PREVALENCE

AND

RELATIVE PROPORTIONS

OF

AND

HOSPITAL EPIDEMIOLOGY

CENTRAL VENOUS CATHETER USE

Medical
Center

No./Total

No. of Patients
With CVCs
ICU

A
B
C
D
E
F
Total

24/256
144/431
163/472
154/554
151/375
82/371
718/2,459

8 (33%)
38 (26%)
84 (52%)
44 (29%)
12 (8%)
26 (32%)
212 (30%)

IN INTENSIVE

December 2003

CARE UNIT (ICU)

AND

NON-ICU PATIENTS

No. of CVCs
Non-ICU

No./
Patients

ICU

Non-ICU

16 (67%)
106 (74%)
79 (48%)
110 (71%)
139 (92%)
56 (68%)
506 (70%)

27/256
155/431
177/472
163/554
151/375
88/371
761/2,459

11
43
95
48
12
29
238

16
112
82
115
139
59
523

CVC = central venous catheter; ICU = intensive care unit.

FIGURE 2. Types of central venous catheters identified during the pointprevalence survey. ICU = intensive care unit; CVC = central venous
catheter; PICC = peripherally inserted central catheter.
FIGURE 1. Sites of central venous catheter insertion in a 1-day pointprevalence survey among the six medical centers participating in the
Prevention Epicenter Program of the Centers for Disease Control and
Prevention. ICU = intensive care unit; PICC = peripherally inserted central
catheter.

commonly used in non-ICU patients (Fig. 1). More than
80% of CVCs in ward patients were subclavian or PICCs.
CVC Types
The most commonly used catheters were nontunneled CVCs (349 of 756, 46%) followed by tunneled CVCs
(176 of 756, 23%), totally implanted devices (120 of 756,
16%), and PICCs (111 of 756, 15%) (Fig. 2). In the ICUs,
74% of catheters used were nontunneled CVCs. The use of
tunneled CVCs, totally implanted devices, and PICCs was
seen more often among non-ICU patients (346 of 517, 67%).
DISCUSSION

CVCs provide much needed vascular access in critically ill patients, but their use can lead to serious complications, including BSIs. In the past, research on the prevention of complications largely focused on the population
of patients with the highest use of CVCs (ie, patients in
the ICU). Because of the increasing acuity of the condi-

tions of patients admitted to hospitals, we believe that
CVCs are increasingly being used outside of the ICU. The
lack of information on the frequency of such use prompted us to perform a 1-day prevalence survey among hospitals participating in the Prevention Epicenter Program.
Not surprisingly, our study found that the overall
rate of CVC use was highest among patients in the ICUs
(mean device utilization rate, 55.4%). However, there was
considerable variation in the utilization rates among the
participating medical centers, which ranged from a low of
30% to a high of 80%, even though all six were large tertiary-care referral hospitals. In contrast to the ICUs, the
wards had a much lower rate of CVC use. This is not an
unexpected finding. However, it is notable that, despite the
lower utilization rate among non-ICU patients, the actual
number of CVCs identified in patients on the wards was
more than twice that for ICU patients (523 vs 238, respectively, or 2.2 times higher). In addition, most of the CVCs
used outside of the ICUs were tunneled, totally implanted,
or peripherally inserted, devices traditionally used for
longer durations and associated with different risk factors
for BSI compared with nontunneled CVCs. This may affect
future prevention efforts aimed at non-ICU CVCs.
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We believe that this is one of the first large-scale
prospective studies to identify the high number of CVCs
being used outside of the ICU. Our findings have several
important implications. Because central vascular catheterization is a known risk factor for BSIs, we should expect
that a significant number of infections will occur in
patients on the wards who have CVCs. A study of hospitalacquired bacteremias in English hospitals between 1997
and 2000 reported that 40% of nosocomial bacteremias
occurred in general surger y and general medicine
patients.19 Given our results, we should actually expect
the number of nosocomial BSIs coming from patients on
the wards to exceed that from patients in the ICU. Indeed,
Lyytikainen et al., in a study of four Finnish hospitals during 1999 to 2000, found that 74% of their BSIs were seen
outside of the ICU.20 Recent data from a statewide candidemia surveillance program revealed that more than
half (56%) of Candida BSIs in a survey of Iowa hospitals
occurred among patients on general wards rather than in
ICUs.21 In another center participating in the Prevention
Epicenter Program, 75% of all nosocomial BSIs within a 6month period occurred outside of the ICU. Fifty-two percent of these were catheter associated (data not shown).
The prevention of catheter-associated BSI has been
addressed by recent CDC guidelines.22 The guidelines recommend (1) educating and training healthcare providers
who insert and maintain catheters; (2) using maximal sterile barrier precautions during CVC insertion; (3) using a
2% chlorhexidine preparation for skin antisepsis; (4) avoiding routine replacement of CVCs as a strategy to prevent
infection; and (5) using antiseptic- or antibiotic-impregnated short-term CVCs only if the infection rate is high
despite adherence to other strategies (ie, education and
training, maximal sterile barrier precautions, and 2%
chlorhexidine for skin antisepsis). These guidelines are
largely based on studies performed on ICU patients with
CVCs. We have shown that there are differences in the epidemiology of CVCs in patients within and outside of the
ICU: femoral CVCs are found more frequently in ICU
patients, and PICCs are used more frequently in ward
patients. We anticipate that there will also be differences in
host risk factors and how long catheters stay in place
between patients in ICUs and patients in non-ICU wards,
although these features were not explored in our pointprevalence survey. Are guidelines for the prevention of
catheter-associated BSIs applicable to CVCs maintained on
the wards, as they were developed based on the experience in the ICU? Our study suggests that additional surveillance of CVC use outside of the ICU is needed. Such
data will allow healthcare workers to develop protocols
that decrease the risk of CVC-associated BSIs in non-ICU
patients and thereby reduce morbidity and mortality.
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